Reaction
Intracranial Tumour Haemorrhage reporting signals
As of the last recalculation, Intracranial Tumour Haemorrhage appears in 379 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is VEMURAFENIB (PRR 66.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Vemurafenib | 14 | 66.4 | 66.5 |
| Temozolomide | 22 | 60.8 | 60.9 |
| Encorafenib | 8 | 45.3 | 45.3 |
| Ipilimumab | 32 | 44.4 | 44.4 |
| Ado-Trastuzumab Emtansine | 5 | 33.0 | 33.0 |
| Azacitidine For | 9 | 27.8 | 27.8 |
| Nivolumab | 36 | 22.5 | 22.5 |